{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:44:13Z","timestamp":1768689853741,"version":"3.49.0"},"reference-count":17,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,8,31]]},"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1136\/ejhpharm-2021-002946","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T17:25:17Z","timestamp":1631640317000},"page":"e19-e19","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series"],"prefix":"10.1136","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4251-2843","authenticated-orcid":false,"given":"Mar\u00eda Del Pilar","family":"Brice\u00f1o-Casado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel David","family":"Gil-Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"De-La-Calle-Riaguas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"2024102217201673000_30.4.e19.1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"2024102217201673000_30.4.e19.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1915327"},{"key":"2024102217201673000_30.4.e19.3","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14268"},{"key":"2024102217201673000_30.4.e19.4","unstructured":"Committee for Medicinal Products for Human Use (CHMP) . Ajovy, INN-fremanezumab. European Medicines Agency. assessment report, 2019. Available: www.ema.europa.eu\/contact [Accessed 10 Jun 2021]."},{"key":"2024102217201673000_30.4.e19.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30083-2"},{"key":"2024102217201673000_30.4.e19.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709038"},{"key":"2024102217201673000_30.4.e19.7","doi-asserted-by":"crossref","first-page":"E2211","DOI":"10.1212\/WNL.0000000000006640","article-title":"Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled regain study","volume":"91","author":"Detke","year":"2018","journal-title":"Neurology"},{"key":"2024102217201673000_30.4.e19.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130733"},{"key":"2024102217201673000_30.4.e19.9","first-page":"212","article-title":"Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison","volume":"44","author":"Brice\u00f1o-Casado","year":"2020","journal-title":"Farm Hosp"},{"key":"2024102217201673000_30.4.e19.10","doi-asserted-by":"crossref","DOI":"10.1007\/s40122-021-00264-x","article-title":"Real-world evidence for control of chronic migraine patients receiving CGRP monoclonal antibody therapy added to onabotulinum toxin A: a retrospective chart review","author":"Blumenfeld","year":"2021","journal-title":"Pain Ther"},{"key":"2024102217201673000_30.4.e19.11","doi-asserted-by":"crossref","unstructured":"Porta-Etessam J , Gonz\u00e1lez-Garc\u00eda N , Guerrero L . Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class. Neurologia 2020.doi:10.1016\/j.nrl.2020.10.009","DOI":"10.1016\/j.nrleng.2020.10.008"},{"key":"2024102217201673000_30.4.e19.12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/head.13729","article-title":"Non-responders to treatment with antibodies to the CGRP-receptor may profit from a switch of antibody class","volume":"60","author":"Ziegeler","year":"2020","journal-title":"Headache"},{"key":"2024102217201673000_30.4.e19.13","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01069-1"},{"key":"2024102217201673000_30.4.e19.14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143527","article-title":"Effects of anti-calcitonin gene-related peptide for migraines: a systematic review with meta-analysis of randomized clinical trials","volume":"20","author":"Huang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024102217201673000_30.4.e19.15","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-021-01247-1","article-title":"Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)","volume":"22","author":"Vernieri","year":"2021","journal-title":"J Headache Pain"},{"key":"2024102217201673000_30.4.e19.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-019-0993-0","article-title":"A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life","volume":"20","author":"Leonardi","year":"2019","journal-title":"J Headache Pain"},{"key":"2024102217201673000_30.4.e19.17","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-013-0385-0"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-002946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:21:07Z","timestamp":1729642867000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-002946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,22]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/ejhpharm-2021-002946"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-002946","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}